SCHEMBL28296128

SCHEMBL28296128

COC(=O)C1=CC=CNN=C1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.35
ALDH1A1 P00352 5/20 0.34
KDM4E B2RXH2 4/20 0.34
GLA P06280 2/20 0.34
GAA P10253 2/20 0.34
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CA12 O43570 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
CA14 Q9ULX7 1/20 0.33
MAPK1 P28482 1/20 0.33
KDM4C Q9H3R0 1/20 0.33
LMNA P02545 1/20 0.32
MAP2K1 Q02750 1/20 0.31
MAPT P10636 2/20 0.31
CFTR P13569 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4334916 0.81 CA12 (0.32) TSHRALDH1A1CA1CA2TDP1
SCHEMBL6209354 0.77
SCHEMBL29107802 0.71 NPSR1 (0.33) TSHRALDH1A1KDM4EGLAGAA
SCHEMBL5552219 0.70 KDM4E (0.33) TSHRALDH1A1KDM4EGLAGAA
SCHEMBL29065451 0.70 NPSR1 (0.35) TSHRALDH1A1KDM4EGLAGAA
SCHEMBL6645426 0.69 NPSR1 (0.34) TSHRALDH1A1KDM4EGLAGAA
SCHEMBL6645420 0.69 NPSR1 (0.34) TSHRALDH1A1KDM4EGLAGAA
SCHEMBL22747795 0.68
SCHEMBL6414618 0.65 TSHR (0.37) TSHRALDH1A1KDM4EGAACA1
SCHEMBL27209677 0.63 TSHR (0.39) TSHRALDH1A1KDM4EGAACA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109843892-B Oxadiazepinone derivatives and their use in the treatment of hepatitis B infections 诺维拉治疗公司 2022-01-25 CN disclosed
CN-109843892-A Dislike diazepine ketone derivatives and its purposes in treatment hepatitis B infection 诺维拉治疗公司 2019-06-04 CN disclosed